Targeted co-delivery of curcumin and TRAIL via engineered extracellular vesicles: a synergistic therapy against resistant cancers
{{output}}
Renal cell carcinoma (RCC) is a resistant malignancy with a rising global incidence, thereby highlighting an urgent need for innovative treatment strategies. Curcumin (CUR), a natural polyphenolic compound, is promising for cancer treatment. However, its clini... ...
